|
COQ2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62947433324234E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.83884027396653E-13 |
| Normal-vs-Stage2 |
5.138100E-03 |
| Normal-vs-Stage3 |
1.83099979622625E-10 |
| Normal-vs-Stage4 |
3.47820000001775E-06 |
| Stage1-vs-Stage2 |
3.594600E-01 |
| Stage1-vs-Stage3 |
6.752800E-01 |
| Stage1-vs-Stage4 |
7.466400E-01 |
| Stage2-vs-Stage3 |
2.693600E-01 |
| Stage2-vs-Stage4 |
5.430600E-01 |
| Stage3-vs-Stage4 |
5.489800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62969637784727E-12 |
| Normal-vs-AfricanAmerican |
2.116500E-03 |
| Normal-vs-Asian |
7.572800E-04 |
| Caucasian-vs-AfricanAmerican |
4.539800E-01 |
| Caucasian-vs-Asian |
9.143400E-01 |
| AfricanAmerican-vs-Asian |
7.329000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36709540857305E-11 |
| Normal-vs-Female |
3.33066907387547E-15 |
| Male-vs-Female |
4.184000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.701800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.51169965434406E-10 |
| Normal-vs-Age(61-80Yrs) |
7.33191285462453E-13 |
| Normal-vs-Age(81-100Yrs) |
7.80100428698915E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.525600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.623600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.726000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.110000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.890100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.991800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.11686224105279E-12 |
| Normal-vs-Grade 2 |
2.96918045705752E-12 |
| Normal-vs-Grade 3 |
3.84137166520304E-14 |
| Normal-vs-Grade 4 |
5.87209999999283E-05 |
| Grade 1-vs-Grade 2 |
1.516430E-03 |
| Grade 1-vs-Grade 3 |
1.357460E-03 |
| Grade 1-vs-Grade 4 |
1.504600E-03 |
| Grade 2-vs-Grade 3 |
9.117400E-01 |
| Grade 2-vs-Grade 4 |
3.835600E-01 |
| Grade 3-vs-Grade 4 |
2.893800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.588580E-01 |
| ccA subtype-vs-ccB subtype |
1.81465953374982E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8594999984245E-08 |
| Normal-vs-N1 |
2.738000E-01 |
| N0-vs-N1 |
4.951000E-01 |
|
|
